H. Barton Grossman
Papers
1
Total Citations
55
H-Index
1
About
H. Barton Grossman is a leading urologic oncologist whose research has fundamentally advanced the surgical management of bladder cancer. His key contributions center on optimizing radical cystectomy and pelvic lymph node dissection, particularly through the adoption of robotic techniques. In his seminal 2010 study, "Robot Assisted Extended Pelvic Lymphadenectomy at Radical Cystectomy: Lymph Node Yield Compared With Second Look Open Dissection" (55 citations), Grossman rigorously demonstrated that robot-assisted lymph node dissection achieves comparable lymph node yields to open surgery, validating the oncologic efficacy of minimally invasive approaches. This work helped establish robotic cystectomy as a viable standard, reducing patient morbidity without compromising cancer control. Beyond this landmark paper, Grossman has been instrumental in developing clinical guidelines for bladder cancer staging and treatment, and his broader portfolio includes influential studies on neoadjuvant chemotherapy and biomarkers for disease recurrence. With a career spanning decades and hundreds of citations, his research has directly shaped urologic practice, improving outcomes for patients with muscle-invasive bladder cancer. Grossman remains a respected voice in surgical oncology, mentoring the next generation of urologic surgeons.
Research Focus
Key Achievements
Top Papers
- 1